Rock Springs Capital Management LP Clearside Biomedical, Inc. Transaction History

Rock Springs Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.0 - $6.12 $975,000 - $5.97 Million	-975,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $222,800 - $571,200	40,000 Added 4.28%	975,000 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$6.73 - $8.74 $6.29 Million - $8.17 Million	935,000	935,000 $8.17 Million

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $63.2M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.